Calum Crake

Calum Crake has a diverse work experience spanning over a decade. Calum began their career as an Analyst at Evercore Partners from June 2009 to September 2011. Calum then joined the University of Oxford in 2011 and completed a PhD in Biomedical Engineering, focusing on improving drug delivery for cancer treatment through the combination of focused ultrasound, magnetically-targeted microbubbles, and passive acoustic monitoring techniques. During their time at Oxford, they presented their research at conferences and published several papers.

Following their PhD, Calum worked as a Consultant at OxSonics Limited in October to December 2015. Calum then joined Brigham and Women's Hospital and Harvard Medical School as a Research Fellow from January 2016 to December 2017.

In 2017, Calum joined OxSonics Therapeutics as a Biomedical Engineer and later progressed to the role of Senior Ultrasound Engineer from January to May 2019. Calum then took on the position of Ultrasound Lead from June 2019 to June 2021. Currently, Calum serves as the Associate Director of Engineering at OxSonics Therapeutics, starting in July 2021.

Overall, Calum Crake has gained comprehensive experience in biomedical engineering, research, and leadership roles, with a specific focus on improving cancer treatment through ultrasound technology.

Calum Crake's education history is as follows:

Calum Crake attended the University of Oxford from 2004 to 2008, where they earned a Bachelor's degree in Engineering Science. Following this, they pursued further education at the same institution from 2011 to 2015 and obtained a Doctor of Philosophy (PhD) in Biomedical/Medical Engineering. Calum's educational background primarily focuses on engineering and biomedical/medical engineering.